Adial Pharmaceuticals, Inc. Proceeds from Issuance of Warrants
Adial Pharmaceuticals, Inc. (ADIL) reported Proceeds from Issuance of Warrants of $2.20 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2025-11-13
- Adial Pharmaceuticals, Inc. proceeds from issuance of warrants for the quarter ending 2025-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. proceeds from issuance of warrants for fiscal 2023 was $3.38M.
| Period end | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.20M 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $3.80M 10-K · filed 2025-03-04 | ||||
| 2023-12-31 | $3.38M 10-K · filed 2025-03-04 | ||||
| 2022-02-28 | $100.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |